TY - JOUR
T1 - Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
AU - Jin, Ying
AU - Andersen, Genevieve
AU - Yorgov, Daniel
AU - Ferrara, Tracey M.
AU - Ben, Songtao
AU - Brownson, Kelly M.
AU - Holland, Paulene J.
AU - Birlea, Stanca A.
AU - Siebert, Janet
AU - Hartmann, Anke
AU - Lienert, Anne
AU - van Geel, Nanja
AU - Lambert, Jo
AU - Luiten, Rosalie M.
AU - Wolkerstorfer, Albert
AU - Wietze van der Veen, J. P.
AU - Bennett, Dorothy C.
AU - Taïeb, Alain
AU - Ezzedine, Khaled
AU - Kemp, E. Helen
AU - Gawkrodger, David J.
AU - Weetman, Anthony P.
AU - Kõks, Sulev
AU - Prans, Ele
AU - Kingo, Külli
AU - Karelson, Maire
AU - Wallace, Margaret R.
AU - McCormack, Wayne T.
AU - Overbeck, Andreas
AU - Moretti, Silvia
AU - Colucci, Roberta
AU - Picardo, Mauro
AU - Silverberg, Nanette B.
AU - Olsson, Mats
AU - Valle, Yan
AU - Korobko, Igor
AU - Böhm, Markus
AU - Lim, Henry W.
AU - Hamzavi, Iltefat
AU - Zhou, Li
AU - Mi, Qing-Sheng
AU - Fain, Pamela R.
AU - Santorico, Stephanie A.
AU - Spritz, Richard A.
PY - 2016
Y1 - 2016
N2 - Vitiligo is an autoimmune disease in which depigmented skin results from the destruction of melanocytes, with epidemiological association with other autoimmune diseases. In previous linkage and genome-wide association studies (GWAS1 and GWAS2), we identified 27 vitiligo susceptibility loci in patients of European ancestry. We carried out a third GWAS (GWAS3) in European-ancestry subjects, with augmented GWAS1 and GWAS2 controls, genome-wide imputation, and meta-analysis of all three GWAS, followed by an independent replication. The combined analyses, with 4,680 cases and 39,586 controls, identified 23 new significantly associated loci and 7 suggestive loci. Most encode immune and apoptotic regulators, with some also associated with other autoimmune diseases, as well as several melanocyte regulators. Bioinformatic analyses indicate a predominance of causal regulatory variation, some of which corresponds to expression quantitative trait loci (eQTLs) at these loci. Together, the identified genes provide a framework for the genetic architecture and pathobiology of vitiligo, highlight relationships with other autoimmune diseases and melanoma, and offer potential targets for treatment
AB - Vitiligo is an autoimmune disease in which depigmented skin results from the destruction of melanocytes, with epidemiological association with other autoimmune diseases. In previous linkage and genome-wide association studies (GWAS1 and GWAS2), we identified 27 vitiligo susceptibility loci in patients of European ancestry. We carried out a third GWAS (GWAS3) in European-ancestry subjects, with augmented GWAS1 and GWAS2 controls, genome-wide imputation, and meta-analysis of all three GWAS, followed by an independent replication. The combined analyses, with 4,680 cases and 39,586 controls, identified 23 new significantly associated loci and 7 suggestive loci. Most encode immune and apoptotic regulators, with some also associated with other autoimmune diseases, as well as several melanocyte regulators. Bioinformatic analyses indicate a predominance of causal regulatory variation, some of which corresponds to expression quantitative trait loci (eQTLs) at these loci. Together, the identified genes provide a framework for the genetic architecture and pathobiology of vitiligo, highlight relationships with other autoimmune diseases and melanoma, and offer potential targets for treatment
U2 - https://doi.org/10.1038/ng.3680
DO - https://doi.org/10.1038/ng.3680
M3 - Article
C2 - 27723757
SN - 1061-4036
VL - 48
SP - 1418
EP - 1424
JO - Nature Genetics
JF - Nature Genetics
IS - 11
ER -